- Home
- NTHI vs CHGG Comparison
NTHI vs CHGG Comparison
Compare NTHI & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | CHGG |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3M | 117.4M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NTHI | CHGG |
|---|---|---|
| Price | $4.31 | $0.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 281.9K | ★ 1.2M |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.15 |
| EPS | N/A | ★ N/A |
| Revenue | $39,990.00 | ★ $376,908,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.01 | $0.52 |
| 52 Week High | $12.99 | $1.87 |
Technical Indicators
Market Signals| Indicator | NTHI | CHGG |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 48.01 |
| Support Level | $4.18 | $0.75 |
| Resistance Level | $5.79 | $1.01 |
| Average True Range (ATR) | 0.42 | 0.07 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 48.61 | 31.68 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.